Low dose Oral Interferon Alpha 2a in HIV-1 Seropositive Patients: A Double-blind, Placebo-controlled Trial

ISSN： 0921-299X

Source： Biotherapy, Vol.11, Iss.4, 1998-01, pp. : 229-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term treatment with recombinant interferon alpha-2b prolongs survival of asymptomatic Hiv-infected individuals

By Rivero J.

Biotherapy, Vol. 10, Iss. 2, 1997-01 ,pp. : 107-113

Springer Publishing Company

Access to resources Recommend Favorite

Up-regulation of HIV-1 transduction in nondividing cells by double-strand DNA break-inducing agents

By Smith Johanna

Biotechnology Letters, Vol. 33, Iss. 2, 2011-02 ,pp. : 243-252

Springer Publishing Company

Access to resources Recommend Favorite

Interferon antibodies in patients with infectious diseases.

By Antonelli G.

Biotherapy, Vol. 10, Iss. 1, 1997-01 ,pp. : 7-14

Springer Publishing Company

Access to resources Recommend Favorite

Improvement of human interferon alpha secretion by Lactococcus lactis

By Zhang Qiuxiang Zhong Jin Liang Xiaobo Liu Wenjun Huan Liandong

Biotechnology Letters, Vol. 32, Iss. 9, 2010-09 ,pp. : 1271-1277

Springer Publishing Company

Access to resources Recommend Favorite

Purification and characterization of prokaryotically expressed human interferon-2

By Li Mingcai Huang Dongyang

Biotechnology Letters, Vol. 29, Iss. 7, 2007-07 ,pp. : 1025-1029

Springer Publishing Company

Access to resources Recommend Favorite